期刊文献+

肿瘤蛋白MDMX与抑制剂PMI作用机制的分子动力学研究

Molecular Dynamics Insight into the Interaction Mechanism of Inhibitor PMI with MDMX
下载PDF
导出
摘要 恢复抑癌蛋白p53的功能已经成为一种治疗癌症的新途径。本文采用分子动力学模拟和MM-PBSA方法计算了抑制剂PMI与肿瘤蛋白MDMX的结合自由能。结果表明范德华相互作用驱动了PMI与MDMX的结合。同时也使用基于残基对的自由能分解方法计算了残基–残基相互作用,结果不仅表明PMI的5个残基能与MDMX产生强烈的相互作用,而且也表明CH-CH,CH-π,π-π相互作用主导了PMI在MDMX疏水性裂缝中的结合。我们期望这个研究能为抑制p53-MDMX相互作用药物的研发提供理论上的启示。 Restoration of p53 function is considered to be a new therapeutic strategy for anti-cancers. Molecular Dynamics (MD) simulations coupled with Molecular Mechanics/Possion-Boltzman Surface Area (MM-PBSA) method were used to study the mechanism of the PMI-MDMX interaction. The results show that van der walls energy drives the PMI-MDMX interaction. Calculations based on residue-residue interaction were also performed, and the results not only suggest that five residues of PMI can produce strong interaction with MDMX, but also the CH-CH, CH-π, π-π interactions predominate the binding of PMI in the hydrophobic cleft of MDMX. We expect that this study can contribute significantly to the designs of the potent inhibitors inhibiting the PMI-MDMX interaction.
出处 《计算生物学》 2012年第3期27-33,共7页 Hans Journal of Computational Biology
基金 国家自然科学基金(Nos. 11104164) 山东交通学院博士启动资金和校自然基金。
  • 相关文献

参考文献1

二级参考文献28

  • 1蒋勇军,曾敏,周先波,邹建卫,俞庆森.CDK2-抑制剂结合自由能计算[J].化学学报,2004,62(18):1751-1754. 被引量:11
  • 2胡建平,孙庭广,陈慰祖,王存新.谷氨酰胺结合蛋白的分子动力学模拟和自由能计算[J].化学学报,2006,64(20):2079-2085. 被引量:12
  • 3Vousden K H, Lane D P. p53 in health and disease [J]. Nat. Rev. Mol. Cell. Biol., 2007, 8:275.
  • 4Shmueli A, Oren M. Regulation of p53 by Mdm2: Fate is in the numbers [J]. Mol. Cell. , 2004, 13. 4.
  • 5Uldrijan S, Pannekoek W J, Vousden K H. An es- sential function of the extreme C-terminus of MDM2 can be provided by MDMX [J]. EMBO. J. , 2007, 26 : 102.
  • 6Xue W, Zender L, Meithing C, et al. and tumour clearance is triggered by p53 in routine liver earcinomas [J]. Nature. , Senescence restoration 2007, 445:656.
  • 7Ventura A, Kirsch D G, Mclaughlin M E, et al. Restoration of p53 function leads to tumour regres- sion in vivo [J]. Nature. , 2007, 445:661.
  • 8Martins C P, Brown-Swigart L, Evan G I. Modeling the therapeutic efficacy of p53 restoration in tumors[J]. Cell., 2006, 127:1323.
  • 9Marine J C, Dyer M A, Joehemsen A G. MDMX: from bench to bedside [J]. J. Cell. Sci., 2007, 120:371.
  • 10Pazgier M, Liu M, Zou G, etal. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX [J]. Proc. Natl. Acad. Sci. , 2009, 106:4665.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部